FF 
Pflndp al lnvc5i>g aio»''^>^ogf«m Dif»clor (LasI first, tru(S<ij0): 
BIOGRAPHICAL SKETCH 
Gfve ffie following information for kay paraonnal and consultants and cofUborators. Bagin with tba pdndpaf 
investigator/program director. Photocopy this page for each person. 
Gabriel N. Hortobagyi 
7/22/46 
Chairman, Breaat and Gynecologic 
Lai Oncoloc 
CuuvA 1 (aegtn ivr;/? D3CC3i3Uf€3i6 Of Olhef Ifuusl pro(eSSiOfl3l &PuC3 
fion. Such as nursing 
and include postdoctoral training.) ' 
INSTITUTION AND LOCATION 
DEGREE 
YEAR 
CONPERRED 
FIELD OF STUDY 
Universidad Natl of Colombia 
M.D. 
1970 
Medicine 
List in chn>;oio5ici 
past three years and to represen.atrve earGer publications pertinent to this appTication. DO NOT EXCEED TWO PAGES. ^ 
POSTGRADUATE TRAINING AJ<D EMPLOYMENT 
1971-1974 Znt Ked Resident, St. Luke's Hospital, Cleveland, OH 
1974-1976 Fellow Medical Oncology, U.T, M.D. Anderson Hosp, Houston 
1976- 1977 Faculty Associate, Medical Breast Service, DTMDACC 
1977- 1980 Assistant Professor of Medicine, UTMDACC 
1980-1985 Associate Professor of Medicine, UTMDACC 
1980-1985 Director, Fellowship Program, Dept. Med. One., UTMDACC 
1984- 1992 Chief, Breast Medical Oncology Service, UTMDACC 
1985- pres Professor of Medicine, UTMDACC 
1991- pres Nylene Eckles Professor of Breast Cancer Research, UTMDACC 
1992- 1993 Chairman, Breast and Gynecologic Medical Oncology, UTMDACC 
CERTIFICATION 
1975 Diplomat, American Board of Internal Medicine 
1977 Diplomat, American Board of Internal Medicine (Medical Oncology) 
HONORS 
1977 Nylene Eckles Fellowship in Breast Cancer Research 
1964 Mario Caitan Yanguas Lecturer 
1991 Nylene Eckles Professorship in Breast Cancer Research 
SELECTED PUBLICATIONS (from a list of 316 published, and 18 in press) 
•Hortobagyi GN, Buzdar AU: Management of locally advanced breast cancer. Am J 
Clin Oncol (CCT) 11:597-601, 1988. 
• Hortobagyi CN, Ames FC, Buzdar AU, Kau SH, McKeese HD, Paulus D, Hug V, Holmes 
FA, Romsdahl KM, Fraschini C, McBride CM, Martin RC, Montague E: Management of 
stage III primary breast cancer with primary chemotherapy, surgery, and radiation 
therapy. Cancer 62:2507-2516, 1988. 
• Hortobagyi CN: The role of high-dose chemotherapy with autologous bone marrow 
transplantation in the treatment of breast cancer. Bone Marrow Transplantation 
3:525-530, 1988. 
• Hortobagyi ON, Frye D, Buzdar AU, Ewer MS, Fraschini C, Hug V, Ames F, Montague 
E, Carrasco CH, Hackay B, Benjeimin RS: Decreased cardiac toxicity of doxorubicii\- 
administered by continuous intravenous infusion in combination chemotherapy for 
metastatic breast cancer. Cancer 63:37-45, 1989. 
• McCready DR, Hortobagyi CN, Kau SW, Smith TL, Buzdar AU, Balch CM: The 
prognostic eignl f icance of lymph node metastases after preoperative chemotherapy 
for locally advanced breast cancer. Arch Surg 124:21-25, 1989. 
• Hortobagyi CN, Yap HY, Kau SW, Fraschini C, Ewer MS, Chawla SP, Benjamin RS: 
A comparative study of doxorubicin and epirublcln in patients with metastatic 
breast cancer. Am J Clin Oncol (CCT) 12(l):57-62, 1989. 
•Buzdar AU, Kau SW, Smith TL, Hortobagyi CN: Ten-year results of FAC adjuvant 
chemotherapy trial in breast cancer. Am J Clin Oncol (CCT) 12 (2) : 123-128, 
1989. 
• Ro JS, Bresser J, Ro JY , Brasfield F, Hortobagyi C, Blick M: SIS/PDCF-B 
expression in benign and malignant human breast, lesion. Oncogene 4:351-354, 1989. 
Recombinant DNA Research, Volume 19 
[547] 
